Flores-González, Raúl E. https://orcid.org/0009-0001-9745-680X
Goncalves, Christophe
Wirasinghe, Noah
Gaudreault, Veronique https://orcid.org/0009-0008-4798-4541
Noda Ferro, Jesus M.
Coutant, Kelly
Mitchell, Andrew https://orcid.org/0000-0002-2630-4788
Papadopoulos, Theodore https://orcid.org/0009-0005-3004-5298
Cho, Yuen Yi https://orcid.org/0009-0002-5881-4325
Guettler, Elizabeth https://orcid.org/0000-0002-0176-9407
González-Moreno, Daniel R.
Preston, Samuel https://orcid.org/0000-0002-2618-8326
Cai, Feiyang https://orcid.org/0000-0002-9977-4190
Gagnon, Natascha
Jean, Steve https://orcid.org/0000-0001-6881-5781
Landreville, Solange https://orcid.org/0000-0002-9164-0657
Miller, Wilson H. Jr. https://orcid.org/0000-0002-7408-1574
del Rincón, Sonia V. https://orcid.org/0000-0002-6350-0227
Funding for this research was provided by:
FRQS Mitacs VSRN Eye Disease Foundation Fondation du CHU de Québec-Desjardins Centre de recherche en organogénèse expérimentale de l’Université Laval/LOEX.
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-518272)
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-178194)
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-183934)
Article History
Received: 16 April 2025
Revised: 15 December 2025
Accepted: 3 February 2026
First Online: 18 February 2026
Competing interests
: The authors declare no competing interests.
: All animal experiments described were carried out in compliance with the Canadian Council of Animal Care guidelines and regulations. Animal protocols were reviewed and approved by McGill University Animal Care and Use Committee (JGH-8168). The study was approved by the ethics committee and in compliance with institutional review board approval from the 2 participating institutions: Jewish General Hospital (MP-05-2025-452) and CHU de Québec-UL. Written informed consent was obtained from all patients (Tumor microarray), and clinical information was de-identified and used in accordance with the CHU de Québec-UL human research ethics committee that covers the UM biobank samples: #2012-1483/DR-002-1305.